# Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

> **NCT04094688** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 455 (actual)

## Conditions studied

- Colorectal Adenocarcinoma

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Oxaliplatin
- **DRUG:** Leucovorin Calcium
- **DRUG:** Fluorouracil
- **DRUG:** Irinotecan Hydrochloride
- **DRUG:** Irinotecan
- **DIETARY_SUPPLEMENT:** Cholecalciferol
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT04094688
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-10-29
- **Primary completion:** 2024-07-15
- **Final completion:** 2026-07-01
- **Target enrollment:** 455 (ACTUAL)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04094688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04094688, "Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04094688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*